STEVEN NG: Open Payments
NPI 1477959484 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$139 in 6 payments from 5 companies in 2025. Trend: 2023 $80 · 2024 $76 · 2025 $139
Food & beverage: $139
| Company | Payments | Amount |
|---|---|---|
| Travere Therapeutics, Inc. | 2 | $50 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $30 |
| Calliditas Therapeutics US Inc. | 1 | $27 |
| Mallinckrodt Hospital Products Inc. | 1 | $16 |
| Azurity Pharmaceuticals, Inc. | 1 | $16 |
Products named: TARPEYO, ACTHAR, EDARBI.
Industry payments across NY — which companies pay providers there.
